1257554-10-1 Usage
General Description
2-isopropoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine is a chemical compound. Its systematic name includes many components which suggest it is a complex organism with several complexes in its molecule. The description suggests that it contains isopropoxy group, pyridine ring and the tetramethyl group within the molecule. One of its key features is that it includes a 1,3,2-dioxaborolane ring, a chemical group featuring boron, oxygen and carbon atoms, which often confers specific properties on organic chemicals. Not much specific information is publicly available or known about its physical properties or uses, making it a relatively obscure chemical.
Check Digit Verification of cas no
The CAS Registry Mumber 1257554-10-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,5,7,5,5 and 4 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1257554-10:
(9*1)+(8*2)+(7*5)+(6*7)+(5*5)+(4*5)+(3*4)+(2*1)+(1*0)=161
161 % 10 = 1
So 1257554-10-1 is a valid CAS Registry Number.
1257554-10-1Relevant articles and documents
1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES
-
Page/Page column 203, (2010/12/29)
The invention relates to the use of 1H-imidazo[4,5-c]quinolinone derivatives and salts thereof in the treatment of protein and/or lipid kinase dependent diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases; 1H-imidazo[4,5-c] quinolinone derivatives for use in the treatment of protein and/or lipid kinase dependent diseases; a method of treatment against said diseases, comprising administering the 1H- imidazo[4,5-c] quinofinone derivatives to a warm-blooded animal, especially a human; pharmaceutical preparations comprising an 1H-imidazo[4,5-c] quinolinone derivative, especially for the treatment of a protein and/or lipid kinase dependent disease; novel 1 H- imidazo[4,5-c] quinolinone derivatives; and a process for the preparation of the novel 1H- imidazo[4,5-c] quinolinone derivatives.
